Dosidal · Poland
pl:authorisation:100384635
Dosidal is a product record. It identifies a medicine and its regulatory status. It does not advise on use.
| Market | Poland |
|---|---|
| Record | pl:authorisation:100384635 (version 1) |
| Level | authorisation |
| Pack code | not anchored |
| Identifiers | pl-authorisation: 53/17 rpl-product-id: 100384635 |
| Source authority | URPL |
| Read date | |
| authorisation status | validity: 2027-02-20 state: current · read 2026-11-15T02:02:49Z · source: URPL / Rejestr Produktów Leczniczych (Centrum e-Zdrowia export) page |
| identity | atc: N07CA01 authorisation_number: 53/17 common_name: Betahistini dihydrochloridum form: Tabletki holder: Delfarma Sp. z o.o. medicine: Betaserc procedure: IR routes: doustna strength: 8 mg substances: amount: 8 substance: Betahistini dihydrochloridum unit: mg state: current · read 2026-11-15T02:02:49Z · source: URPL / Rejestr Produktów Leczniczych (Centrum e-Zdrowia export) page |
| Signature | ES256 over JCS, key dosidal-record-1.9dbf5d53b1p9vCJF7AraC3jQUSu0a5mlIvAvDseTlID_o57ZWNvJghOdVyY6MrJdzHNiWKnUjQQo31cfwNBK8FI31pw9uQVerify with verify_record (MCP) or POST https://dosidal-api.ai/v1/verify/record; keyring https://dosidal-registry.ai/.well-known/jwks.json |